Search fresh public links, source activity, and ready-to-use post angles for Hemlibra.
Fresh curated links around HEMLIBRA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Obizur (susoctocog alfa) is a recombinant porcine (pig-derived) factor VIII concentrate approved for the on-demand treatment of bleeds in adults with acquired hemophilia A. The pos...
Long-term treatment with Hemlibra (emicizumab) provided sustained protection against bleeding for up to five years in people with hemophilia A, with no new safety concerns identifi...
Upfront treatment with Hemlibra (emicizumab-KXWH) may help reduce hospitalization costs associated with treating bleeds in older adults with acquired hemophilia A (AHA), according...
Rebinyn (nonacog beta pegol) is a recombinant factor IX concentrate used to prevent and treat bleeds, including those occurring during surgery, in children and adults with hemophil...
Denecimig (Mim8), an investigational antibody therapy being developed by Novo Nordisk, continued to maintain low bleeding rates in children, adolescents, and adults with hemophilia...
Hemophilia A is a bleeding disorder caused by a deficiency in the blood-clotting factor VIII (FVIII) protein. Standard treatment usually relies on factor replacement therapy, which...
Once-weekly infusions of Altuvoct (efanesoctocog alfa) — a long-lasting hemophilia treatment marketed in the U.S. as Altuviiio — reduced bleeding in adults and children with hemoph...
From acute bleeds and inhibitor considerations to long-term approaches. The post Hemophilia Management: Emergency Stabilization and Long-Term Strategies appeared first on Hemophili...
Srinagar, Jul 14: The High Court of J&K and Ladakh has directed the Principal, Government Medical College (GMC), Srinagar, to immediately address the shortage of life-saving He...
There is no cure for hemophilia A, but several treatments are available to help prevent and control bleeds, reduce the risk of complications, and improve quality of life. People wi...
Inside the evolving hemophilia treatment landscape, including AAV-based gene therapies, non-factor prophylaxis, and approaches that aim to reduce treatment burden. The post Gene an...
A look at how FVIII/FIX deficiency contributes to variable disease severity and provides the biologic foundation for modern hemophilia therapies. The post Bleeding Response in Hemo...
Shannon Walker, MD, explains the importance of inhibitor screening and how newer hemophilia treatments may affect inhibitor development. The post How inhibitors complicate hemophil...
For couples affected by hemophilia who want to avoid passing the inherited bleeding disorder to their children, early genetic testing — done during the in vitro fertilization (IVF)...
Recognizing acquired hemophilia A (AHA) early and ordering simple blood clotting tests in older patients with unexplained bruising or anemia — a low number of red blood cells — may...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.